These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18436327)
1. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. Pang Z; Lu W; Gao H; Hu K; Chen J; Zhang C; Gao X; Jiang X; Zhu C J Control Release; 2008 Jun; 128(2):120-7. PubMed ID: 18436327 [TBL] [Abstract][Full Text] [Related]
2. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. Lu W; Wan J; She Z; Jiang X J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471 [TBL] [Abstract][Full Text] [Related]
3. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. Pang Z; Gao H; Yu Y; Chen J; Guo L; Ren J; Wen Z; Su J; Jiang X Int J Pharm; 2011 Aug; 415(1-2):284-92. PubMed ID: 21651966 [TBL] [Abstract][Full Text] [Related]
4. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice. Xie YL; Lu W; Jiang XG Behav Brain Res; 2006 Oct; 173(1):76-84. PubMed ID: 16828890 [TBL] [Abstract][Full Text] [Related]
5. Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes. Pang Z; Gao H; Chen J; Shen S; Zhang B; Ren J; Guo L; Qian Y; Jiang X; Mei H Int J Nanomedicine; 2012; 7():3421-32. PubMed ID: 22848168 [TBL] [Abstract][Full Text] [Related]
6. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898 [TBL] [Abstract][Full Text] [Related]
7. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Aktaş Y; Yemisci M; Andrieux K; Gürsoy RN; Alonso MJ; Fernandez-Megia E; Novoa-Carballal R; Quiñoá E; Riguera R; Sargon MF; Celik HH; Demir AS; Hincal AA; Dalkara T; Capan Y; Couvreur P Bioconjug Chem; 2005; 16(6):1503-11. PubMed ID: 16287248 [TBL] [Abstract][Full Text] [Related]
8. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate. Kang YS; Pardridge WM J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody. Wu D; Pardridge WM Drug Metab Dispos; 1998 Sep; 26(9):937-9. PubMed ID: 9733674 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor. Kang YS; Bickel U; Pardridge WM Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897 [TBL] [Abstract][Full Text] [Related]
11. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622 [TBL] [Abstract][Full Text] [Related]
12. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor. Yoshikawa T; Pardridge WM J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704 [TBL] [Abstract][Full Text] [Related]
13. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844 [TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB. Liu Z; Zhao H; Shu L; Zhang Y; Okeke C; Zhang L; Li J; Li N Drug Dev Ind Pharm; 2015 Mar; 41(3):353-61. PubMed ID: 25784073 [TBL] [Abstract][Full Text] [Related]
15. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker. Deguchi Y; Kurihara A; Pardridge WM Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961 [TBL] [Abstract][Full Text] [Related]
16. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes. Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and brain uptake of lactoferrin in rats. Ji B; Maeda J; Higuchi M; Inoue K; Akita H; Harashima H; Suhara T Life Sci; 2006 Jan; 78(8):851-5. PubMed ID: 16165165 [TBL] [Abstract][Full Text] [Related]
18. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system. Wu D; Pardridge WM J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978 [TBL] [Abstract][Full Text] [Related]
19. OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability. Bao H; Jin X; Li L; Lv F; Liu T J Mater Sci Mater Med; 2012 Aug; 23(8):1891-901. PubMed ID: 22569733 [TBL] [Abstract][Full Text] [Related]
20. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Pang Z; Feng L; Hua R; Chen J; Gao H; Pan S; Jiang X; Zhang P Mol Pharm; 2010 Dec; 7(6):1995-2005. PubMed ID: 20957995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]